Abstract
Approximately 15 % of PD patients with Parkinson Disease (PD) have the familial type and 5–10 % of these are known to have monogenic forms with either an autosomal dominant or a recessive inheritance pattern. Here, we report on a family carrying the A53T SNCA mutation and we review SNCA mutation phenotypes by comparing point mutations within each other as well as with duplication and triplication.
References
Ahn TB, Kim SY, Kim IY, Park SS, Lee DS, Min HJ et al. (2008) Alpha-synuclein gene duplication is present in sporadic Parkinson's disease. Neurol 70:43–49
Appel-Cresswell S, VilarinoGuell C, Encarnacion M et al (2013) Alphasynuclein p. H50Q, a novel pathogenic mutation for Parkinson disease. Mov Disord 28:811–813
Berg D, Niwar M, Maass S, Zimprich A, Moller JC, Wuellner U et al (2005) Alphasynuclein and Parkinson’s disease: implications from the screening of more than 1,900 patients. Mov Disord 20(9):1191–1194
Bonifati V (2014) Genetics of Parkinson’s disease– state of the art, 2013. Parkinsonism Relat Disord 20(1):23–28
Bostantjopoulou S, Katsarou Z, Papadimitriou A, Veletza V, Hatzigeorgiou G, Lees A (2001) Clinical features of parkinsonian patients with the alpha-synuclein (G209A) mutation. Mov Disord 16(6):1007–1013
Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S et al (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet 364:1167–1169
Elia AE, Petrucci S, Fasano A, Guidi M, Valbonesi S, Bernardini L et al (2013) Alpha-synuclein gene duplication: marked intrafamilial variability in two novel pedigrees. Mov Disord 28(6):813–817
Farrer M (2004) Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 55:174–179
Ferese R, Modugno N, Campopiano R, Santilli M, Zampatti S, Giardina E, et al. (2015) Four copies of SNCA responsible for autosomal dominant Parkinson’s Disease in two Italian siblings. Parkinsons Dis 546462:1–6
Fuchs J, Nilsson C, Kachergus J, Munz M, Larsson EM, Schüle B et al (2007) Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology 68:916–922
Golbe LI, Di Iorio G, Sanges G, Lazzarini AM, La Sala S, Bonavita V et al. (1996) Clinical genetic analysis of Parkinson's disease in the Contursi kindred. Ann Neurol 40:767–775
Gwinn K, Devine MJ, Jin LW, Johnson J, Bird T, Muenter M et al (2011) Clinical features, with video documentation, of the original familial Lewy body parkinsonism caused by α-synuclein triplication (Iowa kindred). Mov Disord 26:2134–2136
Hoffman-Zacharska D, Koziorowski D, Ross OA, Milewski M, Poznański J, Jurek M et al (2013) Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson’s disease. Parkinsonism Relat Disord 19:1057–1060
Howell MJ, Schenck CH (2015) Rapid eye movement sleep behavior disorder and neurodegenerative disease. JAMA Neurol 72(6):707–712
Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, French Parkinson’s Disease Genetics Study Group et al (2009) Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms. Arch Neurol 66(1):102–108
Itokawa K, Sekine T, Funayama M, Tomiyama H, Fukui M, Yamamoto et al (2013) A case of α-synuclein gene duplication presenting with head-shaking movements. Mov Disord 28:384–387
Kara E, Kiely AP, Proukakis C, Hernandez DG, Nacheva E, Pittman AM et al (2015) A 6.4 Mb duplication of the alpha-synuclein locus causing fronto-temporal dementia and parkinsonism—phenotype-genotype correlations. JAMA Neurol 71:1162–1171
Kasten M, Klein C (2013) The many faces of alpha-synuclein mutations. Mov Disord 28:697–701
Ki CS, Stavrou EF, Davanos N, Lee WY, Chung EJ, Kim et al (2007) The Ala53Thr mutation in the alpha-synuclein gene in a Korean family with Parkinson disease. Clin Genet 71:471–474
Kiely AP, Asi YT, Kara E, Limousin P, Lewis P et al. (2013) α-synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neurpa 125(5):753–769
Kojovic M, Sheerin UM, Rubio-Agusti I, Saha A, Bras J, Gibbons V et al (2012) Young-onset parkinsonism due to homozygous duplication of α-synuclein in a consanguineous family. Mov Disord 27:1827–1829
Konno T, Ross OA, Puschmann A, Dickson DW, Wszolek ZK (2016) Autosomal dominant Parkinson's disease caused by SNCA duplications. Parkinsonism Relat Disord 22(Suppl 1):S1–S6
Kruger R, Kuhn W, Leenders KL, Sprengelmeyer R, Muller T, Woitalla D et al (2001) Familial parkinsonism with synuclein pathology: clinical and PET studies of A30P mutation carriers. Neurology 56:1355–1362
Langston JW, Sastry S, Chan P, Forno LS, Bolin LM, Di Monte DA (1998) Novel alphasynuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson’s, and Alzheimer’s disease. Exp Neurol 154(2):684–690
Lesage S, Brice A (2009) Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 18:48–59
Lesage S, Anheim M, Letournel F, Bousset L, Honorè A, Rozas N et al. (2013) G51D α-synuclein mutation causes a novel parkinsonian-pyramidal syndrome. Ann Neurol 73(4):459–471
Maremmani C, Rossi G, Tambasco N, Fattori B, Pieroni A, Ramat S et al (2012) The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson’s disease patients. Parkinsonism Relat Disord 18(6):788–793
Markopoulou K, Wszolek ZK, Pfeiffer RF (1995) A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 38(3):373–378
Mezey E, Dehejia AM, Harta G, Tresser N, Suchy SF, Nussbaum RL et al (1998) Alpha synuclein is present in Lewy bodies in sporadic Parkinson’s disease. Mol Psych 3(6):493–499
Michell AW, Barker RA, Raha SK, Raha-Chowdhury R (2005) A case of late onset sporadic Parkinson’s disease with an A53T mutation in alpha-synuclein. JNNP 76(4):596–597
Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ et al (1998) Hereditary form of parkinsonism–dementia. Ann Neurol 43:768–781
Mutez E, Leprêtre F, Le Rhun E, Larvor L, Duflot A, Mouroux V et al (2011) SNCA locus duplication carriers: from genetics to Parkinson disease phenotypes. Hum Mutat 32(4):2079–2090
Nishioka K, Hayashi S, Farrer MJ, Singleton AB, Yoshino H, Imai H et al (2006) Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson’s disease. Ann Neurol 59(2):298–309
Nishioka K, Ross OA, Ishii K, Kachergus JM, Ishiwata K, Kitagawa M et al (2009) Expanding the clinical phenotype of SNCA duplication carriers. Mov Disord 24(12):1811–1819
Olgiati S, Thomas A, Quadri M, Breedveld GJ, Graafland J, Eussen H, Douben H, de Klein A, Onofrj M, Bonifati V (2015) Early-onset parkinsonism caused by alpha-synuclein gene triplication: clinical and genetic findings in a novel family. Parkinsonism Relat Disord. 21(8):981–986
Papadimitriou A, Veletza V, Hadjigeorgiou GM, Patrikiou A, Hirano M, Anastasopoulos I (1999) Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? Neurology 52:651e4
Papapetropoulos S, Paschlis C, Athanassiadou A, Papadimitriou A, Ellul J, Polymeropoulos MH et al. (2001) Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease. J Neurol Neurosurg Psychiatry 70(5):662–665
Pasanen P, Myllykangas L, Siitonen M, Raunio A, Kaakkola S, Lyytinen J et al (2014) Novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s disease-type pathology. Neurobiol Aging 35:2180 e1–2180 e5
Petrucci S, Consoli F, Valente EM (2014) Parkinson disease genetics: a “Continuum” from Mendelian to multifactorial inheritance. Curr Mol Med 14(8):1079–1088
Pimentel MMG, Rodrigues FC, Leite MAA (2015) Parkinson disease: a-synuclein mutational screening and new clinical insight into the p. E46K mutation. Parkinsonism Rel Disord 21(6):586–589
Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A et al (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276:2045e7
Proukakis C, Dudzik CG, Brier T, MacKay DS, Cooper JM, Millhauser GL et al (2013) A novel α-synuclein missense mutation in Parkinson disease. Neurology 80(11):1062–1064
Puschmann A, Ross OA, Vilarino-Guell C, Lincoln SJ, Kachergus JM, Cobb SA et al (2009) A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction. Parkinsonism Rel Disord 15:627e32
R Development Core Team (2012) A language and enviroment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
Seidel K, Schols L, Nuber S, Petrasch-Parwez E, Gierga K, Wszolek Z et al (2010) First appraisal of brain pathology owing to A30P mutant alpha-synuclein. Ann Neurol 67:684e9
Sekine T, Kagaya H, Funayama M, Li Y, Yoshino H, Tomiyama H et al (2010) Clinical course of the first Asian family with Parkinsonism related to SNCA triplication. Mov Disord 25(16):2871–2875
Shin CW, Kim HJ, Park SS, Kim SY, Kim JY, Jeon BS (2010) Two Parkinson’s disease patients with alpha-synuclein gene duplication and rapid cognitive decline. Mov Disord 25(7):957–959
Sironi F, Trotta L, Antonini A, Zini M, Ciccone R, Della Mina E et al. (2010) Alpha-synuclein multiplication analysis in Italian familial Parkinson's disease. Parkinsonism Relat Disord 16(3):228–231
Skirton H, Goldsmith L, Jackson L, Tibben A (2013) Quality in genetic counselling for presymptomatic testing—clinical guidelines for practice across the range of genetic conditions. Eur J Hum Genet 21:256–260
Somme JH, Gomez-Esteban JC, Molano A, Tijero B, Lezcano E, Zarranz JJ (2011) Initial neuropsychological impairments in patients with the E46K mutation of the alpha-synuclein gene (PARK 1). J Neurol Sci 310:86e9
Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA (2001) Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol 49(3):313–319
Tijero B, Gómez-Esteban JC, Lezcano E, Fernández-González C, Somme J, Llorens V, Martínez A, Ruiz-Martínez J, Foncea N, Escalza I, Berganzo K, Aniel-Quiroga MA, Ruiz V, Terán N, Kaufmann H, Zarranz JJ (2013) Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the α synuclein gene. Parkinsonism Relat Disord 19(1):95–100
Tokutake T, Ishikawa A, Yoshimura N, Miyashita A, Kuwano R, Nishizawa M et al (2014) Clinical and neuroimaging features of patient with early-onset Parkinson’s disease with dementia carrying SNCA p. G51D mutation. Parkinsonism Rel Disord 20(2):262–264
Uchiyama T (2008) Prominent psychiatric symptoms and glucose hypometabolism in a family. Neurology 71:1289–1292
Zarranz JJ, Alegre J, Gomez-Esteban JC, Lezcano E, Ros R, Ampuero I et al (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55:164–173
Zarranz JJ, Fernández-Bedoya A, Lambarri I, Gómez-Esteban JC, Lezcano E, Zamacona J, Madoz P (2005) Abnormal sleep architecture is an early feature in the E46K familial synucleinopathy. Mov Disord 20(10):1310–1315
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Tambasco, N., Nigro, P., Romoli, M. et al. A53T in a parkinsonian family: a clinical update of the SNCA phenotypes. J Neural Transm 123, 1301–1307 (2016). https://doi.org/10.1007/s00702-016-1578-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-016-1578-6